Sangrix Inc. carries no debt; cash flow comfortably covers obligations.

Sangrix Inc.'s free cash flow has increased 71.11% from $-7.93M last year to $-2.29M, signaling increasing performance

Sangrix Inc.'s debt to equity ratio is -13.15, signaling that the company spent its equity and risk bankruptcy.

Sangrix Inc.'s debt has increased relative to shareholder equity from 3.11 last year to -13.15 today, signaling weakened financials

Sangrix Inc. has a net cash position, so leverage is healthy.

Sangrix Inc. carries no debt; interest obligations are fully covered.

Sangrix Inc.'s profit margin was -606.95% last year and is -25.95K% this year, signaling decreasing performance

Sangrix Inc.'s short-term assets of $3.54M exceed its short-term liabilities of $372.08K

Sangrix Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Sangrix Inc.'s return on equity of -731.64%, is lower than 15.00%, indicating bad performance

Sangrix Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Sangrix Inc. had positive net income in only 1 out of 5 years, indicating unstable earnings

Sangrix Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Sangrix Inc. has negative free cash flow, indicating cash burn

Sangrix Inc.'s yearly earnings has increased 74.98% since last year from $-17.53M to $-4.39M, signaling increasing performance

Sangrix Inc.'s yearly revenue has decreased 98.63% since last year from $2.89M to $39.49K, signaling decreasing performance

ROIC -16.59% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Sangrix Inc.'s 3-year revenue CAGR of -41.00% is negative, indicating declining revenue over the past 3 years

Sangrix Inc. had revenue growth in only 2 out of 5 years, indicating inconsistent revenue performance

Sangrix Inc. had positive ROE in only 1 out of 5 years, indicating inconsistent returns on equity

Sangrix Inc. has insufficient data to evaluate this check.

Sangrix Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Sangrix Inc. is overvalued relative to its fair value price of 0.00 based on Base EBITDA Valuation model

Sangrix Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Sangrix Inc. has insufficient data to evaluate this check.

Sangrix Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Sangrix Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

Sangrix Inc. has a price-to-sales ratio of 2.71x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue